methylprednisolone and lfm a13

methylprednisolone has been researched along with lfm a13 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carpenter, R; Cetkovic-Cvrlje, M; Chen, CL; Chen, H; Lisowski, E; Uckun, FM; Vassilev, A; Waurzyniak, B; Zheng, Y1

Other Studies

1 other study(ies) available for methylprednisolone and lfm a13

ArticleYear
In vivo pharmacokinetic features, toxicity profile, and chemosensitizing activity of alpha-cyano-beta-hydroxy-beta- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a novel antileukemic agent targeting Bruton's tyrosine kinase.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:5

    Topics: Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Antineoplastic Agents; Area Under Curve; Asparaginase; Biological Availability; Blotting, Western; Body Weight; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia, Experimental; Methylprednisolone; Mice; Mice, Inbred BALB C; Nitriles; Protein-Tyrosine Kinases; Rats; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Vincristine

2002